Fernando Henao-Carrasco

7PUBLICATIONS
72CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersTraditional Chinese medicine and treatments
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 17, 2026
Bone health in patients with cancer: a SEOM-SEIOMM consensus review of risk factors, assessment strategies, and management approaches.

Carmen Beato-Zambrano, Xavier Nogues, Natalia Ramírez-Merino

|Dec 01, 2025
Addition of Ipatasertib to Dual Anti-HER2 Maintenance Therapy in HER2-Positive Metastatic Breast Tumors with PIK3CA Mutations: The Phase Ib SOLTI-1507 IPATHER Trial.

Mafalda Oliveira, Eva Ciruelos, Guillermo Villacampa

|Apr 01, 2024
First-line therapy with palbociclib in patients with advanced HR+/HER2- breast cancer: The real-life study PALBOSPAIN.

N Martínez-Jañez, M Bellet Ezquerra, L M Manso Sanchez

|Feb 01, 2024
Patient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in gBRCA1/2 Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer.

Patricia A Ganz, Hanna Bandos, Tanja Španić

|Oct 30, 2023
Correction: SEOM-GEICAM-SOLTI clinical guidelines for early-stage breast cancer (2022).

Francisco Ayala de la Peña, Silvia Antolín Novoa, Joaquín Gavilá Gregori

|Jun 16, 2023
SEOM-GEICAM-SOLTI clinical guidelines for early-stage breast cancer (2022).

Francisco Ayala de la Peña, Silvia Antolín Novoa, Joaquín Gavilá Gregori

Pageof 2

Frequent Collaborators

3 joint publications

Joaquín Gavilá Gregori

3 joint publications

Eva Ciruelos

3 joint publications

Francisco Ayala de la Peña

2 joint publications

Lucía González Cortijo